These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17616056)

  • 21. Efficacy of tulathromycin or enrofloxacin for initial treatment of naturally occurring bovine respiratory disease in feeder calves.
    Robb EJ; Tucker CM; Corley L; Bryson WL; Rogers KC; Sturgess K; Bade DJ; Brodersen B
    Vet Ther; 2007; 8(2):127-35. PubMed ID: 17616947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An evaluation of the metaphylactic effect of ceftiofur crystalline free Acid in feedlot calves.
    Booker CW; Schunicht OC; Guichon PT; Jim GK; Wildman BK; Pittman TJ; Perrett T
    Vet Ther; 2006; 7(3):257-74. PubMed ID: 17039449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimating the comparative clinical and economic consequences of tulathromycin for treatment of present or anticipated outbreaks of bovine respiratory disease in feedlot cattle in the United States.
    Nautrup BP; Van Vlaenderen I; Gasper SM; Holland RE
    J Anim Sci; 2013 Dec; 91(12):5868-77. PubMed ID: 24126273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Field study of the comparative efficacy of gamithromycin and tulathromycin for the control of undifferentiated bovine respiratory disease complex in beef feedlot calves at high risk of developing respiratory tract disease.
    Torres S; Thomson DU; Bello NM; Nosky BJ; Reinhardt CD
    Am J Vet Res; 2013 Jun; 74(6):839-46. PubMed ID: 23718651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Field study of the comparative efficacy of gamithromycin and tulathromycin for the treatment of undifferentiated bovine respiratory disease complex in beef feedlot calves.
    Torres S; Thomson DU; Bello NM; Nosky BJ; Reinhardt CD
    Am J Vet Res; 2013 Jun; 74(6):847-53. PubMed ID: 23718652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative efficacy of enrofloxacin to that of tulathromycin for the control of bovine respiratory disease and prevalence of antimicrobial resistance in Mannheimia haemolytica in calves at high risk of developing bovine respiratory disease.
    Crosby S; Credille B; Giguère S; Berghaus R
    J Anim Sci; 2018 Apr; 96(4):1259-1267. PubMed ID: 29471391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary lesions and clinical disease response to Mannheimia haemolytica challenge 10 days following administration of tildipirosin or tulathromycin.
    Amrine DE; White BJ; Larson RL; Mosier DA
    J Anim Sci; 2014 Jan; 92(1):311-9. PubMed ID: 24243906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of treatment of cattle with bovine respiratory disease with tulathromycin.
    Wellman NG; O'Connor AM
    J Vet Pharmacol Ther; 2007 Jun; 30(3):234-41. PubMed ID: 17472655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical disease and lung lesions in calves experimentally inoculated with Histophilus somni five days after metaphylactic administration of tildipirosin or tulathromycin.
    Confer AW; Snider TA; Taylor JD; Montelongo M; Sorensen NJ
    Am J Vet Res; 2016 Apr; 77(4):358-66. PubMed ID: 27027834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic characterization of susceptible and multi-drug resistant Mannheimia haemolytica isolated from high-risk stocker calves prior to and after antimicrobial metaphylaxis.
    Snyder ER; Alvarez-Narvaez S; Credille BC
    Vet Microbiol; 2019 Aug; 235():110-117. PubMed ID: 31282368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of 2 vaccination programs in feedlot calves at ultra-high risk of developing undifferentiated fever/bovine respiratory disease.
    Wildman BK; Perrett T; Abutarbush SM; Guichon PT; Pittman TJ; Booker CW; Schunicht OC; Fenton RK; Jim GK
    Can Vet J; 2008 May; 49(5):463-72. PubMed ID: 18512457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the clinical field efficacy and safety of florfenicol and tilmicosin for the treatment of undifferentiated bovine respiratory disease of cattle in western Canada.
    Hoar BR; Jelinski MD; Ribble CS; Janzen ED; Johnson JC
    Can Vet J; 1998 Mar; 39(3):161-6. PubMed ID: 9524721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of tulathromycin in the treatment of bovine respiratory disease associated with induced Mycoplasma bovis infections in young dairy calves.
    Godinho KS; Rae A; Windsor GD; Tilt N; Rowan TG; Sunderland SJ
    Vet Ther; 2005; 6(2):96-112. PubMed ID: 16094558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of tulathromycin injectable solution for the treatment of naturally occurring Swine respiratory disease.
    Nutsch RG; Hart FJ; Rooney KA; Weigel DJ; Kilgore WR; Skogerboe TL
    Vet Ther; 2005; 6(2):214-24. PubMed ID: 16094568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of short-term health and performance effects related to prophylactic administration of tulathromycin versus tilmicosin in long-hauled, highly stressed beef stocker calves.
    Nickell JS; White BJ; Larson RL; Blasi DA; Renter DG
    Vet Ther; 2008; 9(2):147-56. PubMed ID: 18597253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standard PK/PD concepts can be applied to determine a dosage regimen for a macrolide: the case of tulathromycin in the calf.
    Toutain PL; Potter T; Pelligand L; Lacroix M; Illambas J; Lees P
    J Vet Pharmacol Ther; 2017 Jan; 40(1):16-27. PubMed ID: 27501187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of enrofloxacin and ceftiofur sodium for the treatment of relapse of undifferentiated fever/bovine respiratory disease in feedlot cattle.
    Abutarbush SM; Schunicht OC; Wildman BK; Hannon SJ; Jim GK; Ward TI; Booker CW
    Can Vet J; 2012 Jan; 53(1):57-62. PubMed ID: 22753964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative cost-effectiveness of treatment of feedlot calves with ivermectin versus treatment with a combination of fenbendazole, permethrin, and fenthion.
    Guichon PT; Jim GK; Booker CW; Schunicht OC; Wildman BK; Brown JR
    J Am Vet Med Assoc; 2000 Jun; 216(12):1965-9. PubMed ID: 10863598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-inferiority of nitric oxide releasing intranasal spray compared to sub-therapeutic antibiotics to reduce incidence of undifferentiated fever and bovine respiratory disease complex in low to moderate risk beef cattle arriving at a commercial feedlot.
    Regev-Shoshani G; McMullin B; Nation N; Church JS; Dorin C; Miller C
    Prev Vet Med; 2017 Mar; 138():162-169. PubMed ID: 25975664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimum inhibitory concentrations of tulathromycin against respiratory bacterial pathogens isolated from clinical cases in European cattle and swine and variability arising from changes in in vitro methodology.
    Godinho KS; Keane SG; Nanjiani IA; Benchaoui HA; Sunderland SJ; Jones MA; Weatherley AJ; Gootz TD; Rowan TG
    Vet Ther; 2005; 6(2):113-21. PubMed ID: 16094559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.